Vtv Therapeutics Stock Market Value
| VTVT Stock | USD 15.63 0.41 2.56% |
| Symbol | VTv |
vTv Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.37) | Revenue Per Share 0.411 | Return On Assets (0.41) | Return On Equity (3.62) |
The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
VTv Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VTv Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VTv Therapeutics.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in VTv Therapeutics on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding vTv Therapeutics or generate 0.0% return on investment in VTv Therapeutics over 720 days. VTv Therapeutics is related to or competes with DiaMedica Therapeutics, Lyra Therapeutics, and Centessa Pharmaceuticals. vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered tre... More
VTv Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VTv Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess vTv Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.62 | |||
| Information Ratio | 0.0069 | |||
| Maximum Drawdown | 17.16 | |||
| Value At Risk | (5.42) | |||
| Potential Upside | 7.12 |
VTv Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VTv Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VTv Therapeutics' standard deviation. In reality, there are many statistical measures that can use VTv Therapeutics historical prices to predict the future VTv Therapeutics' volatility.| Risk Adjusted Performance | 0.039 | |||
| Jensen Alpha | 0.2208 | |||
| Total Risk Alpha | (0.53) | |||
| Sortino Ratio | 0.0079 | |||
| Treynor Ratio | (0.31) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VTv Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
vTv Therapeutics Backtested Returns
Currently, vTv Therapeutics is unstable. vTv Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0263, which indicates the firm had a 0.0263% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for vTv Therapeutics, which you can use to evaluate the volatility of the company. Please validate VTv Therapeutics' Semi Deviation of 3.49, coefficient of variation of 2479.86, and Risk Adjusted Performance of 0.039 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%. VTv Therapeutics has a performance score of 2 on a scale of 0 to 100. The entity has a beta of -0.51, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning VTv Therapeutics are expected to decrease at a much lower rate. During the bear market, VTv Therapeutics is likely to outperform the market. vTv Therapeutics right now has a risk of 4.15%. Please validate VTv Therapeutics treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to decide if VTv Therapeutics will be following its existing price patterns.
Auto-correlation | 0.14 |
Insignificant predictability
vTv Therapeutics has insignificant predictability. Overlapping area represents the amount of predictability between VTv Therapeutics time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of vTv Therapeutics price movement. The serial correlation of 0.14 indicates that less than 14.0% of current VTv Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 33.67 |
vTv Therapeutics lagged returns against current returns
Autocorrelation, which is VTv Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VTv Therapeutics' stock expected returns. We can calculate the autocorrelation of VTv Therapeutics returns to help us make a trade decision. For example, suppose you find that VTv Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
VTv Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VTv Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VTv Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VTv Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
VTv Therapeutics Lagged Returns
When evaluating VTv Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VTv Therapeutics stock have on its future price. VTv Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VTv Therapeutics autocorrelation shows the relationship between VTv Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in vTv Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VTv Stock Analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.